Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma

NCT02163057 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Cancer

Interventions

BIOLOGICAL: INO-3112
DEVICE: CELLECTRA™-5P

Sponsor

Inovio Pharmaceuticals

Collaborators

[object Object]